# Sildenafil to Treat HIV-Associated Pulmonary Hypertension

> **NCT00327080** · PHASE1 · TERMINATED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 20 (actual)

## Conditions studied

- HIV

## Interventions

- **PROCEDURE:** MRI
- **DRUG:** L-NMMA
- **DRUG:** Acetylcholine

## Key facts

- **NCT ID:** NCT00327080
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-05-12
- **Primary completion:** 2009-03-18
- **Final completion:** 2009-03-18
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2019-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00327080

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00327080, "Sildenafil to Treat HIV-Associated Pulmonary Hypertension". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00327080. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*